| Stage | FSTR | % of rev | RS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $139M | 100.00% | $5.2B | 100.00% | RS ×37.63 |
| Gross profit | $31M | 22.28% | $1.5B | 27.89% | RS +5.6pp |
| Operating income | $6M | 4.44% | $552M | 10.59% | RS +6.2pp |
| Pre-tax income | $5M | 3.93% | $532M | 10.20% | RS +6.3pp |
| Net income | $3M | 2.25% | $403M | 7.74% | RS +5.5pp |
| Stage | FSTR | RS | Gap · A − B |
|---|---|---|---|
| Revenue | $139M100.00% | $5.2B100.00% | RS ×37.63 |
| Gross profit | 22.28%$31M | 27.89%$1.5B | RS +5.6pp |
| Operating income | 4.44%$6M | 10.59%$552M | RS +6.2pp |
| Pre-tax income | 3.93%$5M | 10.20%$532M | RS +6.3pp |
| Net income |
| 2.25%$3M |
| 7.74%$403M |
| RS +5.5pp |
No disclosed counterparties: FSTR, RS.